Get started
FRKLN GG ETF UNITSFRKLN GG ETF UNITSFRKLN GG ETF UNITS

FRKLN GG ETF UNITS

No trades
See on Supercharts
Overview
Analysis Holdings Discussions Technicals Seasonals

FRGG chart


Full chart

Key stats


Assets under management (AUM)
—
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
4.6%
Shares outstanding
—
Expense ratio
0.90%

About FRKLN GG ETF UNITS


Issuer
Franklin Resources, Inc.
Brand
Franklin
Home page
etf.franklintempleton.com
Inception date
Apr 15, 2024
Index tracked
MSCI World ex Australia Index - AUD - Benchmark TR Net
Replication method
Physical
Management style
Active
Dividend treatment
Distributes
Primary advisor
Franklin Templeton Australia Ltd.
ISIN
AU60FRT00091
The Fund aims to outperform the MSCI World ex Australia Index NR, in Australian dollar terms after fees and expenses (but before taxes), over the medium to longer term.

Classification


Asset Class
Equity
Category
Size and style
Focus
Total market
Niche
Growth
Geography
Global
Weighting scheme
Proprietary
Selection criteria
Proprietary

FRGG analysis


What's in the fund
Exposure type
StocksBonds, Cash & Other
Technology Services
Finance
Health Technology
Stock breakdown by region
3%72%17%5%

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to FRGG via country, focus, and more.